The Role of Omalizumab in Patients With Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss): Comment on the Article by Jachiet et al

Arthritis Rheumatol. 2017 Apr;69(4):868-870. doi: 10.1002/art.40012. Epub 2017 Feb 28.

Authors

Aikaterini Detoraki¹, Gilda Varricchi¹, Arturo Genovese¹, Gianni Marone², Giuseppe Spadaro³

Affiliations

¹ University of Naples Federico II.
² University of Naples Federico II and CNR Institute of Experimental Endocrinology and Oncology G. Salvatore.
³ University of Naples Federico II, Naples, Italy.

PMID: 27992689
DOI: 10.1002/art.40012

No abstract available

Publication types

Letter
Comment

MeSH terms

Antibodies, Anti-Idiotypic
Churg-Strauss Syndrome / immunology*
Granulomatosis with Polyangiitis*
Humans
Omalizumab
Recurrence

Substances

Antibodies, Anti-Idiotypic
anti-IgE antibodies
Omalizumab